MELISSA SKINNER: Open Payments
NPI 1376034066 · ENNIS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$667 in 34 payments from 20 companies in 2025. Trend: 2023 $320 · 2024 $333 · 2025 $667
Food & beverage: $667
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 6 | $145 |
| Lilly USA, LLC | 3 | $67 |
| Novo Nordisk Inc | 3 | $56 |
| ABBVIE INC. | 3 | $45 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Amgen Inc. | 2 | $33 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| Abbott Laboratories | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
Products named: Korlym, JARDIANCE, VRAYLAR, Wegovy, RECORLEV, Auvelity, EVENITY, SHINGRIX.
Industry payments across TX — which companies pay providers there.
